We start with the target.
We begin with the protein we want to modulate. A receptor driving disease progression. A surface marker on pathological tissue. An enzyme involved in extracellular remodeling. The biology defines the molecule.
How it works
Target. Design. Validate. Deliver.
Four steps. Weeks, not years. Measured validation on the path to product.
We design the molecule.
Our generative models create novel protein sequences for a specific target interface. These sequences have never existed before in nature or in any library. Every design campaign produces multiple candidates optimized for affinity, stability, and manufacturability.
We validate experimentally.
Every candidate enters our validation workflow. Interaction, function, and selectivity measured across the assays the target requires. Measured, not predicted.
We advance toward product.
We nominate the lead from validation and run the tests that gate the next step: formulation compatibility, stability under product-relevant conditions, and the characterization required to move into development or partner evaluation.
We run the full loop in-house, from design through validation to product.
Get in touch